The investment will help NDCFS drive its organic and inorganic growth and consolidate its leadership position in the growing ophthalmology healthcare segment
Mahindra Partners announced an investment of Rs 206.5 crore in New Delhi-based Centre for Sight (NDCFS). This investment will help NDCFS drive its organic and inorganic growth and consolidate its leadership position in the growing Indian ophthalmology healthcare segment. As part of this transaction, the promoters have further invested Rs 20 crore and early investor Matrix Partners India fully exited its stake in NDCFS. A total of Rs 226.5 crore has been invested, in a mix of primary and secondary investment, by Mahindra Partners and the promoters of NDCFS.
“We are excited to partner with the Centre for Sight as it enters its next phase of growth,” said Parag Shah, Managing Partner, Mahindra Partners. “It is a leader in ophthalmology in India and we want to be a part of its evolution and growth into the dominant Indian eye care brand. This investment also reflects Mahindra’s core values of doing well while doing good for the communities and society in which we operate. We have great confidence in Dr Mahipal and his team, their strong focus on execution and the large, growing market they serve, will help drive the company’s future growth.”
“This new investment aligns with the demographic catered to by our first healthcare investment, Medwell Ventures, which operates a home healthcare chain under the Nightingales brand.” Mr. Shah added. “It also creates a very measurable impact on the lives of people, serving close to seven lakh patients last year.”
“Our focus on the principles of efficiency, precision, integrity and compassion has brought us from a single small set-up to a proud chain with state of the art ophthalmic care facilities. We believe in our tagline of ‘Every eye deserves the best’ and raising the bar of ophthalmic care thus ensuring the delivery of the latest technology to various parts of our country,” said Prof (Dr) Mahipal S Sachdev, CMD, NDCFS.